1
/
of
1
Elabscience
SKU:PKSQ050090
Recombinant Vibrio cholerae Toxin B Protein
Recombinant Vibrio cholerae Toxin B Protein
Regular price
$178.00 USD
Regular price
Sale price
$178.00 USD
Unit price
/
per
Shipping calculated at checkout.
Couldn't load pickup availability
Introducing the Recombinant Vibrio cholerae Toxin B Protein, a cutting-edge product meticulously engineered to cater to the needs of the scientific community. This protein, derived from the notorious Vibrio cholerae bacterium, showcases unparalleled potential in various research applications.
Crafted through advanced recombinant DNA technology, this protein exhibits exceptional purity and stability, ensuring reliable and reproducible results. Its precise composition guarantees optimal performance, making it an indispensable tool for scientists and researchers alike.
The Recombinant Vibrio cholerae Toxin B Protein boasts a myriad of applications, including but not limited to the study of cholera pathogenesis, vaccine development, and elucidation of toxin-host interactions. Its versatility enables researchers to delve into the intricate mechanisms underlying cholera infection, paving the way for groundbreaking discoveries and advancements in the field.
With its unrivaled quality, this protein offers an unparalleled opportunity to unravel the mysteries surrounding Vibrio cholerae and its toxin B. Its high affinity for specific receptors facilitates in-depth investigations into the toxin's binding properties, ultimately leading to a comprehensive understanding of its pathogenicity.
Furthermore, the Recombinant Vibrio cholerae Toxin B Protein is meticulously manufactured under stringent quality control measures, ensuring utmost purity and integrity. Each batch undergoes rigorous testing to guarantee consistency and reliability, providing researchers with the utmost confidence in their experimental outcomes.
In conclusion, the Recombinant Vibrio cholerae Toxin B Protein stands as a pinnacle of scientific innovation, offering an invaluable resource for researchers seeking to unravel the complexities of Vibrio cholerae and its toxin B. With its exceptional purity, stability, and versatility, this protein is poised to revolutionize the field of cholera research, propelling scientific advancements and paving the way for a brighter future.
Crafted through advanced recombinant DNA technology, this protein exhibits exceptional purity and stability, ensuring reliable and reproducible results. Its precise composition guarantees optimal performance, making it an indispensable tool for scientists and researchers alike.
The Recombinant Vibrio cholerae Toxin B Protein boasts a myriad of applications, including but not limited to the study of cholera pathogenesis, vaccine development, and elucidation of toxin-host interactions. Its versatility enables researchers to delve into the intricate mechanisms underlying cholera infection, paving the way for groundbreaking discoveries and advancements in the field.
With its unrivaled quality, this protein offers an unparalleled opportunity to unravel the mysteries surrounding Vibrio cholerae and its toxin B. Its high affinity for specific receptors facilitates in-depth investigations into the toxin's binding properties, ultimately leading to a comprehensive understanding of its pathogenicity.
Furthermore, the Recombinant Vibrio cholerae Toxin B Protein is meticulously manufactured under stringent quality control measures, ensuring utmost purity and integrity. Each batch undergoes rigorous testing to guarantee consistency and reliability, providing researchers with the utmost confidence in their experimental outcomes.
In conclusion, the Recombinant Vibrio cholerae Toxin B Protein stands as a pinnacle of scientific innovation, offering an invaluable resource for researchers seeking to unravel the complexities of Vibrio cholerae and its toxin B. With its exceptional purity, stability, and versatility, this protein is poised to revolutionize the field of cholera research, propelling scientific advancements and paving the way for a brighter future.
Share
